Shares of Diploma PLC (LON:DPLM – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is GBX 5,605.71.
DPLM has been the topic of a number of research reports. Berenberg Bank reissued a “buy” rating and set a GBX 6,350 target price on shares of Diploma in a research report on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Diploma from GBX 5,400 to GBX 6,000 and gave the company a “buy” rating in a report on Tuesday, November 18th. Jefferies Financial Group upped their target price on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a report on Thursday, September 11th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 4,440 target price on shares of Diploma in a research report on Wednesday, August 6th. Finally, Peel Hunt reissued a “buy” rating and issued a GBX 6,150 price target on shares of Diploma in a research report on Tuesday, November 18th.
View Our Latest Stock Report on Diploma
Insider Activity at Diploma
Diploma Trading Up 0.3%
DPLM traded up GBX 15 during trading on Friday, hitting GBX 5,465. 172,063 shares of the stock were exchanged, compared to its average volume of 620,420. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The firm has a 50 day simple moving average of GBX 5,399.57 and a 200 day simple moving average of GBX 5,170.09. The firm has a market cap of £7.32 billion, a price-to-earnings ratio of 43.97, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma has a 1 year low of GBX 3,532 and a 1 year high of GBX 5,700.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
- Five stocks we like better than Diploma
- How to Calculate Stock Profit
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- What is a Death Cross in Stocks?
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Short Selling – The Pros and Cons
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
